Slide 1: Getinge Group Year-end report January – December 2012
GETINGE GROUP Year-end report January – December 2012 25 January 2013 Johan Malmquist, CEO Ulf Grunander, CFO
Slide 2: Q4 2012 - Trends in organic order intake
Q4 2012 - Trends in organic order intake 2012 2012 Q4 YTD MS EC IC TOT MS EC IC TOT Western Europe -11.3% -8.7% -0.9% -8.3% -4.9% -2.6% -2.3% -3.5% USA and Canada 14.1% -6.8% 1.8% 5.6% 6.1% -8.4% 0.6% 0.7% Rest of the world 2.9% 10.4% -9.1% 1.4% 16.2% 10.8% 6.1% 13.1% Total 1.0% -5.3% -2.5% -1.3% 6.
Slide 3: Q4 2012 - Consolidated results
Q4 2012 - Consolidated results 2012 2011 2012 2011 Q4 Q4 Change % YTD YTD Change % Net sales, SEK million 7 816 7 354 6.3 % 24 248 21 854 11.0 % Gross margin 51.5 % 51.7 % -0.2 % 52.4 % 52.2 % 0.2 % Operating cost, SEK -2 241 -2 022 10.8 % -8 470 -7 302 16.0 % million EBITA before 1 943 1 921 1.1 %
Slide 4: Q4 2012 - Medical Systems
Q4 2012 - Medical Systems 2012 2011 2012 2011 Q4 Q4 Change % YTD YTD Change % Net sales, SEK million 4 295 3 847 11.6 % 13 089 11 031 18.7 % Gross margin % 58.2 % 58.8 % -0.6 % 58.6 % 57.7 % 0.9 % Operating cost, SEK -1 362 -1 201 13.4 % -5 236 -4 234 23.7 % million EBITA before 1 263 1 174 7.6 % 2
Slide 5: Medical Systems Highlights
Q4 2012 - Medical Systems Highlights • Integration of Atrium on track. • Restructuring activities in the Cardiovascular division proceeding as planned. • New sales company in South Africa.
Slide 6: Q4 2012 - Extended Care
Q4 2012 - Extended Care 2012 2011 2012 2011 Q4 Q4 Change % YTD YTD Change % Net sales, SEK million 1 776 1 647 7.8 % 5 990 5 751 4.2 % Gross margin % 48.7 % 48.8 % -0.1 % 51.0 % 51.8 % -0.8 % Operating cost, SEK -521 -475 9.7 % -1 871 -1 800 3.9 % million EBITA before 373 352 6.0 % 1 274 1 278 -0.3
Slide 7: Extended Care Highlights
Q4 2012 - Extended Care Highlights • Acquisition of TSS completed. • Integration of TSS initiated and closure of San Antonio plant decided.
Slide 8: Q4 2012 - Infection Control
Q4 2012 - Infection Control 2012 2011 2012 2011 Q4 Q4 Change % YTD YTD Change % Net sales, SEK million 1 745 1 860 -6.2 % 5 170 5 072 1.9 % Gross margin % 37.9 % 39.7 % -1.8 % 38.4 % 40.5 % -2.1 % Operating cost, SEK -358 -346 3.5 % -1 363 -1 268 7.5 % million EBITA before 306 395 -22.5 % 631 798 -2
Slide 9: Infection Control Highlights
Q4 2012 – Infection Control Highlights • Acquisition of SteriTec, USA, strengthens Infection Control’s consumables franchise. • Infection Control aims to implement an extensive activities programme to significantly improve the business area’s profitability.
Slide 10: Financials Q4
Financials Q4 2012 2011 2012 2011 Q4 Q4 YTD YTD Cash flow from operation, SEK million 1,457 1,424 3,687 3,496 Cash conversion, % 70.7% 69.0% 64.1% 65.1% Net Debt, SEK million 18,382 17,109 Equity, SEK million 15,200 14,636 Equity/assets ratio, % 35.4% 35.3% Net debt/equity ratio, multiple 1.21 1.17
Slide 11: Outlook 2013
GETINGE GROUP \ Outlook 2013
Slide 12: Q&A
GETINGE GROUP \ Q&A
Slide 13: Forward looking information
Forward looking information This document contains forward-looking information based on the current expectations of the Getinge Group’s management. Although management deems that the expectations presented by such forward-looking information are reasonable, no guarantee can be given that these expec